Literature DB >> 8721984

Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms.

P Prendergast1, Z Pan, D P Edwards.   

Abstract

We have used circular permutation and phasing electrophoretic mobility shift assays to determine the ability of the A and B forms of human progesterone receptor (PR) to bend target DNA. Studies were done with baculovirus-expressed full-length receptors purified to apparent homogeneity. By circular permutation analysis, both forms of PR induced substantial distortions in the structure of target DNA with calculated distortion angles (alpha D) of 57 degrees for PR-A and 84 degrees for PR-B. The apparent bend centers for both forms of PR were similarly located a few base pairs (-4 to -2 bp) from the middle of the progesterone response element. No differences were detected in the magnitude of distortion or apparent bend centers when PR was bound to hormone agonist (R5020) or the antagonist RU486. Phasing analysis, which can determine the orientation of a DNA bend, revealed that both forms of PR mediated directional bends toward the major groove of the DNA helix. Calculated directed bend angles (alpha B) were 40 degrees for PR-B and 31 degrees for PR-A. The chromatin high mobility group protein HMG-1, which acts as an accessory factor to enhance the binding affinity of purified PR for progesterone response elements, had minimal influence on PR-mediated DNA bending. This result, taken together with the fact that HMG-1 can form a ternary complex with PR and DNA, is consistent with the conclusion that HMG-1 facilitates PR binding by stabilizing a receptor-induced DNA conformation that is required for assembly of a high affinity PR-DNA complex. The results of this study also suggest that DNA bending may be coupled to transcriptional regulation since PR-B is generally a stronger transcriptional activator than PR-A and also mediates a larger bend in target DNA than PR-A.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8721984     DOI: 10.1210/mend.10.4.8721984

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

1.  Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.

Authors:  Guy Verrijdt; Annemie Haelens; Erik Schoenmakers; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

2.  Thermodynamic analysis of progesterone receptor-promoter interactions reveals a molecular model for isoform-specific function.

Authors:  Keith D Connaghan-Jones; Aaron F Heneghan; Michael T Miura; David L Bain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-02       Impact factor: 11.205

3.  Thermodynamic dissection of progesterone receptor interactions at the mouse mammary tumor virus promoter: monomer binding and strong cooperativity dominate the assembly reaction.

Authors:  Keith D Connaghan-Jones; Aaron F Heneghan; Michael T Miura; David L Bain
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

4.  Prebending the estrogen response element destabilizes binding of the estrogen receptor DNA binding domain.

Authors:  J Kim; G de Haan; A M Nardulli; D J Shapiro
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

Review 5.  Structural and functional analysis of domains of the progesterone receptor.

Authors:  Krista K Hill; Sarah C Roemer; Mair E A Churchill; Dean P Edwards
Journal:  Mol Cell Endocrinol       Date:  2011-07-22       Impact factor: 4.102

6.  Nucleosome-mediated synergism between transcription factors on the mouse mammary tumor virus promoter.

Authors:  S Chávez; M Beato
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

7.  High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells.

Authors:  V Boonyaratanakornkit; V Melvin; P Prendergast; M Altmann; L Ronfani; M E Bianchi; L Taraseviciene; S K Nordeen; E A Allegretto; D P Edwards
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.